Literature DB >> 16131735

Neurological soft signs are associated with APOE genotype, age and cognitive performance.

N T Lautenschlager1, Jing-Shan Wu, S M Laws, O P Almeida, R M Clarnette, K Joesbury, S Wagenpfeil, G Martins, A Paton, S E Gandy, H Förstl, R N Martins.   

Abstract

Neurodegeneration is associated with increased frequency of neurological soft signs (NSS). We designed the present study to investigate the association between NSS and subjective memory complaints, cognitive function and apolipoprotein E genotype in a community-dwelling sample of volunteers participating in an ongoing longitudinal program investigating predictors of cognitive decline. NSS were found to be associated with apolipoprotein E (APOE) epsilon4 genotype (p = 0.015), age (p = 0.012) and poor cognitive performance, as assessed by the Mini Mental State Examination (p = 0.053). There was no significant difference between subjects with and without memory complaints in relation to the frequency of NSS (p = 0.130). The association with age and the APOE epsilon4 genotype suggests that the systematic investigation of NSS may contribute to identify subjects at risk of clinically significant cognitive decline in later life.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131735     DOI: 10.3233/jad-2005-7409

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers.

Authors:  John P John; Vikram Arunachalam; Bhuvaneshwari Ratnam; Mohan K Isaac
Journal:  Compr Psychiatry       Date:  2007-10-15       Impact factor: 3.735

2.  The presence of neurological soft signs along the psychosis proneness continuum.

Authors:  Emma Barkus; John Stirling; Richard Hopkins; Shôn Lewis
Journal:  Schizophr Bull       Date:  2006-01-11       Impact factor: 9.306

3.  Neurological soft signs in aging, mild cognitive impairment, and Alzheimer's disease - the impact of cognitive decline and cognitive reserve.

Authors:  Nadja Urbanowitsch; Christina Degen; Pablo Toro; Johannes Schröder
Journal:  Front Psychiatry       Date:  2015-02-11       Impact factor: 4.157

Review 4.  Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.

Authors:  Ralph N Martins; Victor Villemagne; Hamid R Sohrabi; Pratishtha Chatterjee; Tejal M Shah; Giuseppe Verdile; Paul Fraser; Kevin Taddei; Veer B Gupta; Stephanie R Rainey-Smith; Eugene Hone; Steve Pedrini; Wei Ling Lim; Ian Martins; Shaun Frost; Sunil Gupta; Sid O'Bryant; Alan Rembach; David Ames; Kathryn Ellis; Stephanie J Fuller; Belinda Brown; Samantha L Gardener; Binosha Fernando; Prashant Bharadwaj; Samantha Burnham; Simon M Laws; Anna M Barron; Kathryn Goozee; Eka J Wahjoepramono; Prita R Asih; James D Doecke; Olivier Salvado; Ashley I Bush; Christopher C Rowe; Samuel E Gandy; Colin L Masters
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Neurological soft signs are increased in migraine without aura: relationship with the affective status.

Authors:  Lucio Tremolizzo; Daniele Selvatico; Federico Emanuele Pozzi; Diletta Cereda; Jacopo Cosimo DiFrancesco; Lorenzo Fumagalli; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2022-05-18       Impact factor: 3.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.